Albert Farrugia. (2023) The Evolution of the Safety of Plasma Products from Pathogen Transmission—A Continuing Narrative. Pathogens 12:2, pages 318.
Crossref
Seyed Ali Mohammad ArabzadehFarideh AlizadehAhmad TavakoliHamidreza MollaeiFarah Bokharaei-SalimGharib KarimiMohammad FarahmandHelya Sadat MortazaviSeyed Hamidreza Monavari. (2017) Human parvovirus B19 in patients with beta thalassemia major from Tehran, Iran. Blood Research 52:1, pages 50.
Crossref
Hongxue Li, Miao He, Peibin Zeng, Zhan Gao, Guohui Bian, Chunhui Yang & Wuping Li. (2015) The genomic and seroprevalence of human bocavirus in healthy Chinese plasma donors and plasma derivatives. Transfusion 55:1, pages 154-163.
Crossref
Wei Zhang, Ling Ke, Li Changqing, Yan Zhang & Wuping Li. (2012) Parvovirus B19V DNA contamination in Chinese plasma and plasma derivatives. Journal of Translational Medicine 10:1.
Crossref
Stuart P. Adler & William C. Koch. 2011. Infectious Diseases of the Fetus and Newborn. Infectious Diseases of the Fetus and Newborn
834
860
.
Peter Tattersall & Susan F. Cotmore. 2010. Topley & Wilson's Microbiology and Microbial Infections. Topley & Wilson's Microbiology and Microbial Infections.
G. Caspari & W. H. Gerlich. 2011. Transfusionsmedizin und Immunhämatologie. Transfusionsmedizin und Immunhämatologie
529
574
.
A. Parsyan & D. Candotti. (2007) Human erythrovirus B19 and blood transfusion ? an update. Transfusion Medicine 17:4, pages 263-278.
Crossref
Stuart P. Adler & William C. Koch. 2006. Infectious Diseases of the Fetus and Newborn Infant. Infectious Diseases of the Fetus and Newborn Infant
867
892
.
G. Caspari & W. H. Gerlich. 2004. Transfusionsmedizin. Transfusionsmedizin
599
645
.
Johannes Blümel, Ivo Schmidt, Wolfgang Effenberger, Holger Seitz, Hannelore Willkommen, Hans Herrmann Brackmann, Johannes Löwer & Anna Maria Eis‐Hübinger. (2002) Parvovirus B19 transmission by heat‐treated clotting factor concentrates. Transfusion 42:11, pages 1473-1481.
Crossref
Erik D. Heegaard & Kevin E. Brown. (2002) Human Parvovirus B19. Clinical Microbiology Reviews 15:3, pages 485-505.
Crossref
Ruth Laub & Paul Strengers. (2002) Parvoviruses and blood products. Pathologie Biologie 50:5, pages 339-348.
Crossref
M.J. Vizcaíno. (2002) Seroprevalencia de parvovirus B19. Distribución por edad y sexo. Clínica e Investigación en Ginecología y Obstetricia 29:10, pages 352-354.
Crossref
J.T. Aubin, C. Defer, M. Vidaud, M. Maniez Montreuil & B. Flan. (2003) Large‐Scale Screening for Human Parvovirus B19 DNA by PCR: Application to the Quality Control of Plasma for Fractionation. Vox Sanguinis 78:1, pages 7-12.
Crossref
H. Sakata, H. Ihara, S. Sato, T. Kato, H. Ikeda & S. Sekiguchi. (2003) Efficiency of Donor Screening for Human Parvovirus B19 by the Receptor‐Mediated Hemagglutination Assay Method. Vox Sanguinis 77:4, pages 197-203.
Crossref
Miguel A. Canales, Javier Pinilla, Pablo Mateos, Rosa Martinez Zapico, Teresa Alvarez, Victor M. Jiménez, Manuel Quintana, Ana Villar, Fernando Hernández Navarro & Manuel Magallón. (2003) Human Parvovirus B19 Antibodies Are Less Frequent among Patients Treated with Factor IX Concentrate Inactivated by Ultrafiltration: A Report from a Single Spanish Institution. Vox Sanguinis 74:4, pages 260-261.
Crossref
E.P. Mauser‐Bunschoten, H. L. Zaaijer, A. A. J. van Drimmelen, S. de Vries, G. Roosendaal, H. M. van den Berg & P. N. Lelie. (2003) High Prevalence of Parvovirus B19 lgG Antibodies among Dutch Hemophilia Patients. Vox Sanguinis 74:4, pages 225-227.
Crossref
H. Rollag, B. G. Solheim & J. L. Svennevig. (1998) Viral Safety of Blood Derivatives by Immune Neutralization. Vox Sanguinis 74:S1, pages 213-217.
Crossref
David H. Dockrell, Gregory A. Poland, Thomas E. Smith, Mary E. Jones, Peter C. Wollan, Scott R. Strickland & Claire Pomeroy. (1997) Seroprevalence of parvovirus B19 antibody in HIV positive asymptomatic persons. International Journal of Infectious Diseases 2:2, pages 99-104.
Crossref
C. Prowse, C. A. Ludlam & P. L. Yap. (2003) Human Parvovirus B19 and Blood Products. Vox Sanguinis 72:1, pages 1-10.
Crossref
T.J. Lynch, M.J. Weinstein, D.L. Tankersley, J.C. Fratantoni & J.S. Finlayson. (2003) Considerations of pool size in the manufacture of plasma derivatives. Transfusion 36:9, pages 770-775.
Crossref
A.M. Eis-hübinger, J. Oldenburg, H.-H. Brackmann, B. Matz & K.E. Schneweis. (1996) The Prevalence of Antibody to Parvovirus B19 in Hemophiliacs and in the General Population. Zentralblatt für Bakteriologie 284:2-3, pages 232-240.
Crossref
M.V. Ragni, W.C. Koch & J.A. Jordan. (2003) Parvovirus B19 infection in patients with hemophilia. Transfusion 36:3, pages 238-241.
Crossref
G. Caspari, W. H. Gerlich & P. Kühnl. 1996. Transfusionsmedizin. Transfusionsmedizin
549
584
.
A. M. Eis-Hübinger, I. Wiedemann, J. Blümel, J. Oldenburg, H. H. Brackmann, B. Matz & K. E. Schneweis. 1996. 25. Hämophilie-Symposion Hamburg 1994. 25. Hämophilie-Symposion Hamburg 1994
302
307
.
ED Heegaard & A Hornsleth. (2008) Parvovirus: the expanding spectrum of disease. Acta Paediatrica 84:2, pages 109-117.
Crossref
F McOmishP L YapA JordanH HartB J CohenP Simmonds. (1993) Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction. Journal of Clinical Microbiology 31:2, pages 323-328.
Crossref
A. Grosse-Bley, A. M. Eis-Hübinger, R. Kaiser, J. Oldenburg, H.-H. Brackmann, T. F. Schwarz & K. E. Schneweis. 1993. 23. Hämophilie-Symposion. 23. Hämophilie-Symposion
222
226
.